Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Plasma Analysis for Response Assessment and to DIrect the manaGement of Metastatic Prostate Cancer

NCT04067713 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT04067713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04067713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Plasma Analysis for Response Assessment and to DIrect the manaGement of Metastatic Prostate Cancer
Lead sponsor
University College, London
Phase
Observational
Overall status
Active, not recruiting
Start date
September 20, 2019
Completion date
October 31, 2030
Enrollment
192 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic prostate cancer